Photocarcinogenesis – UV Radiation and Skin Cancer

What is Photocarcinogenesis?

Photocarcinogenesis refers to the multi-step biological process by which ultraviolet (UV) radiation induces or promotes the development of cancer in the skin. UV radiation – from natural sunlight as well as artificial sources such as tanning beds – is the leading environmental risk factor for skin cancer. The process can unfold over decades before a malignant tumor becomes clinically apparent.

Causes and Risk Factors

The primary cause of photocarcinogenesis is chronic or intense exposure to UV radiation, particularly:

• UV-B radiation (wavelength 280–315 nm): directly damages DNA, causing characteristic UV-signature mutations.
• UV-A radiation (wavelength 315–400 nm): penetrates deeper into the skin and generates reactive oxygen species that indirectly damage DNA.

Additional risk factors include:

• Fair skin type (Fitzpatrick skin types I and II)
• History of frequent sunburns, especially during childhood and adolescence
• Use of tanning beds
• Immunosuppression (e.g., after organ transplantation)
• Genetic predisposition (e.g., xeroderma pigmentosum)
• Certain medications that increase photosensitivity (photosensitizers)

Mechanism of Photocarcinogenesis

DNA Damage

UV-B radiation causes characteristic DNA lesions, most notably cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts. These form when adjacent pyrimidine bases (thymine or cytosine) in the DNA strand become covalently linked. If not correctly repaired, these lesions lead to mutations, particularly the characteristic C→T and CC→TT transitions known as UV-signature mutations.

Impairment of DNA Repair

Cells have repair mechanisms – primarily nucleotide excision repair (NER) – to correct UV-induced DNA damage. Chronic or high-intensity UV exposure can overwhelm this capacity. Furthermore, UV-induced mutations in tumor suppressor genes such as TP53 can impair both DNA repair and apoptosis (programmed cell death).

Mutations in Oncogenes and Tumor Suppressor Genes

UV-induced mutations may affect critical regulatory genes:

• TP53 (tumor suppressor gene): mutations lead to uncontrolled cell proliferation; TP53 mutations bearing a UV signature are found in more than 50% of cutaneous squamous cell carcinomas.
• PTCH1: frequently mutated in basal cell carcinoma.
• BRAF and NRAS: relevant to the development of malignant melanoma.

UV-Induced Immunosuppression

UV radiation suppresses both local and systemic skin immune responses. It inhibits the activity of Langerhans cells (dendritic cells of the skin) and promotes the production of immunosuppressive cytokines such as interleukin-10 (IL-10). This allows transformed cells to evade immune surveillance.

Oxidative Stress

UV-A radiation generates reactive oxygen species (ROS) that cause oxidative damage to lipids, proteins, and DNA in skin cells. This indirect DNA damage also contributes to mutagenesis and carcinogenesis.

Associated Cancer Types

Photocarcinogenesis is primarily associated with the following types of skin cancer:

• Basal cell carcinoma (BCC): the most common skin cancer, arising from basal keratinocytes.
• Squamous cell carcinoma (SCC): arising from keratinizing keratinocytes; strongly linked to chronic UV exposure.
• Malignant melanoma: arising from melanocytes; intermittent intense UV exposure and sunburns are key risk factors.

Diagnosis

Early detection of UV-induced skin changes involves:

• Regular skin cancer screening by a dermatologist
• Dermoscopy (dermatoscopy) for evaluation of pigmented skin lesions
• Biopsy and histological examination of suspicious lesions
• Reflectance confocal microscopy at specialized centers

Prevention

Since photocarcinogenesis is primarily caused by UV radiation, consistent UV protection is the most important preventive measure:

• Application of sunscreen with a high sun protection factor (SPF 30 or higher)
• Wearing UV-protective clothing, hats, and sunglasses
• Avoiding direct sun exposure during peak hours (10 a.m. – 4 p.m.)
• Avoiding tanning beds
• Regular skin examinations, especially for high-risk individuals

Treatment

Treatment of UV-related skin cancers depends on the type and stage of cancer:

• Surgical excision: the gold standard for basal cell and squamous cell carcinomas
• Mohs surgery: tissue-sparing technique for tumors in challenging locations
• Radiation therapy: for inoperable tumors or as adjuvant treatment
• Immunotherapy and targeted therapy: especially for metastatic melanoma (e.g., checkpoint inhibitors, BRAF inhibitors)
• Photodynamic therapy (PDT): for precancerous lesions and superficial carcinomas

References

1. World Health Organization (WHO): Ultraviolet radiation and the INTERSUN Programme. WHO, Geneva. Available at: https://www.who.int/uv/en/
2. Brash, D. E. (2015): UV signature mutations. Photochemistry and Photobiology, 91(1), 15–26. DOI: 10.1111/php.12377
3. Narayanan, D. L., Saladi, R. N., Fox, J. L. (2010): Ultraviolet radiation and skin cancer. International Journal of Dermatology, 49(9), 978–986. DOI: 10.1111/j.1365-4632.2010.04474.x